Forte Biosciences Inc (FBRX) — Cash Flow-to-Debt Ratio
Forte Biosciences Inc (FBRX) has a Cash Flow-to-Debt Ratio of -1.08x as of September 2025, meaning its operating cash flow of $-14.00 Million could theoretically repay -1% of its total liabilities ($12.99 Million) in one year. Explore Forte Biosciences Inc (FBRX) cash conversion ratio to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Forte Biosciences Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Forte Biosciences Inc across 10 annual periods. Also explore Forte Biosciences Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Forte Biosciences Inc (2015–2024)
Year-by-year debt coverage analysis for Forte Biosciences Inc. For market capitalisation and broader financial context, see market value of Forte Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.39x | $-30.75 Million | $9.08 Million | ▲ +56.8% |
| 2023 | -7.83x | $-28.71 Million | $3.67 Million | ▼ -204.1% |
| 2022 | -2.57x | $-8.19 Million | $3.18 Million | ▲ +72.9% |
| 2021 | -9.49x | $-16.68 Million | $1.76 Million | ▼ -16.3% |
| 2020 | -8.16x | $-18.42 Million | $2.26 Million | ▼ -462.7% |
| 2019 | -1.45x | $-2.77 Million | $1.91 Million | ▼ -88.9% |
| 2018 | -0.77x | $-34.47 Million | $44.94 Million | ▲ +48.3% |
| 2017 | -1.48x | $-31.13 Million | $20.99 Million | ▼ -42.4% |
| 2016 | -1.04x | $-29.54 Million | $28.36 Million | ▼ -14.3% |
| 2015 | -0.91x | $-21.04 Million | $23.09 Million | — |